By a GenomeWeb staff reporter
NEW YORK (GenomeWeb News) – Combimatrix said today that the New York State Department of Health has given the Irvine, Calif.-based company a clinical laboratory permit to receive specimens for its DNA Array postnatal test from New Yorkers.
Registering provides access to this and other free content.
Already have an account?Login Now.
In PNAS this week: chromosome instability in S. cerevisiae, structural differences and sequence divergence in rice, and more.
The San Diego Union-Tribune takes a look at the work to be done in personalized medicine.
An op-ed in the Wall Street Journal calls for the establishment of a patent court staffed by judges and experts with science backgrounds.
Widespread genome sequencing might not be justified just yet, USA Today reports.